Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
841
self-reported 501–1,000 band
Founded
2006
20 years
Legal entities
1
ACRA
Office countries
2
2 addresses
Funding rounds
None on record
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
Legal entities
Show as table · iNova Pharmaceuticals: 1 registry entity
| INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED | UEN 200617543H |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
iNova Pharmaceuticals is leading the way to better health by constantly searching for new, practical solutions that improve the everyday health and wellbeing of people around the world.
Our portfolio of market-leading consumer health brands and prescription medicines are backed by science and span across the key therapeutic areas of throat, cough, cold & flu, skin care, sun care, pain management, wound care, weight management, natural health supplements among many others.
Headquartered in Singapore, today our products are distributed in over 75 markets across Asia, Australia, New Zealand, Middle East & Africa and Europe.
At iNova pharmaceuticals, we do things differently. iNova believes that if you can imagine it, you make it happen. Every employee has the opportunity to make a real and immediate impact.
Be part of a passionate team, focused on delivering innovative healthcare solutions that improve the lives of people around the world.
Discover why people love working at iNova Pharmaceuticals. We offer an award-winning culture and industry-leading benefits.
iNova Pharmaceuticals is an Equal Opportunity employer. We strongly believe that inclusion and diversity is critical to our success and our people reflect the diversity of the global markets we serve.
Specialties
All 11 specialties
- weight management
- pain management
- dermatology
- cardiology
- respiratory health
- allergy
- prescription
- OTC
- therapeutic skin
- cough and cold
- throat
Locations
2
Countries with an office address2 addresses on record
SingaporeprimaryAustralia
Country footprint
Show as table · Offices in 2 countries
| Countries | 2 |
|---|---|
| Primary country | SG |
All codes: SG AU
Addresses
- SG1 Temasek Avenue, Millenia Tower; 04-01; Singapore, Central Region 039192Primary
- AU12 Help Street, Chatswood; Sydney, NSW 2067
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under iNova Pharmaceuticals?
One Singapore entity on ACRA: INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED (UEN 200617543H), high confidence.
How many people work at iNova Pharmaceuticals?
841 counted staff profiles at January 2026, inside the self-reported 501–1,000 band.
Where does iNova Pharmaceuticals have offices?
Two addresses on record across 2 countries. Primary: 1 Temasek Avenue, Millenia Tower, 04-01, Singapore, Central Region 039192.
Has iNova Pharmaceuticals raised funding?
None linked to this brand.
What does iNova Pharmaceuticals list as its specialties?
11 tags on the brand's own list, among them otc, weight management and cardiology.
Which companies are listed alongside iNova Pharmaceuticals?
91 profiles list iNova Pharmaceuticals as a peer — 99th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Ego Pharmaceuticals and Alphapharm list it back.